Learn how to appeal insurance denials for non-formulary generic drugs. Step-by-step guide to formulary exceptions, internal appeals, and external reviews to save money and keep your medication.
Learn how the FDA proves generic drugs are equivalent to brand-name medications through bioequivalence studies, including the 80-125% rule and pharmacokinetic parameters.
Learn how step therapy rules force patients to try generics first. Discover why insurers use fail-first policies, how to request exceptions, and what new laws protect your right to timely care.
Discover how generic combination products simplify treatment and boost patient compliance. Learn why these integrated therapies cut costs by up to 80% while maintaining the safety and efficacy of brand-name options.
Learn about prior authorization for NTI drugs, why insurers require brand names, and how to navigate the process. Discover the risks of delays and new regulations protecting patient access.
Learn how to qualify for the Extra Help Program (LIS) to lower your Medicare Part D medication costs. Check 2026 income limits, resource rules, and how to apply.
Learn how controlled substance labels and DEA schedule codes work. Understand the difference between Schedule I-V drugs and how they affect your prescriptions.
Learn how to evaluate generic drug coverage and insurance formularies when switching health plans to avoid surprise costs and maximize savings.
Explore the legal clash between 180-day exclusivity and authorized generics. Understand how brand-name strategies impact generic profits and patient costs.
